Cargando…

Expectant Management of Placenta Accreta Spectrum Disorders

Placenta accreta spectrum (PAS) disorder is a potentially life-threatening complication. The incidence of PAS has increased over the past few decades, mainly due to the increased cesarean section rate. While cesarean hysterectomy remains the most standard treatment for the management of PAS, expecta...

Descripción completa

Detalles Bibliográficos
Autor principal: Kondoh, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752198/
https://www.ncbi.nlm.nih.gov/pubmed/35036541
http://dx.doi.org/10.1055/s-0040-1722240
_version_ 1784631836843966464
author Kondoh, Eiji
author_facet Kondoh, Eiji
author_sort Kondoh, Eiji
collection PubMed
description Placenta accreta spectrum (PAS) disorder is a potentially life-threatening complication. The incidence of PAS has increased over the past few decades, mainly due to the increased cesarean section rate. While cesarean hysterectomy remains the most standard treatment for the management of PAS, expectant management is becoming increasingly prevalent to avoid serious maternal morbidity and maintain future fertility. Expectant management is defined as leaving the placenta either partially or fully in situ, and waiting for its spontaneous resorption or expulsion. The success rate of expectant management is high, but intraoperative uncontrolled hemorrhage results in hysterectomy. Moreover, some individuals fail expectant management and require delayed hysterectomy due to complications such as secondary postpartum hemorrhage, sepsis, uterine necrosis, and vesicouterine fistula. As a result of the very limited data currently available, there is no consensus on the optimal strategy for the expectant management of PAS. However, it is clear that a multidisciplinary team approach in tertiary centers is essential for women with PAS. In addition, meticulous preparation is the key to successful expectant management. Here, we describe a surgical strategy designed to reduce perioperative blood loss, which is a minimum requirement to ensure maternal safety. This article also addresses practical issues in expectant management of PAS, based on the published literature and our own experience.
format Online
Article
Text
id pubmed-8752198
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical Publishers, Inc.
record_format MEDLINE/PubMed
spelling pubmed-87521982022-01-13 Expectant Management of Placenta Accreta Spectrum Disorders Kondoh, Eiji Surg J (N Y) Placenta accreta spectrum (PAS) disorder is a potentially life-threatening complication. The incidence of PAS has increased over the past few decades, mainly due to the increased cesarean section rate. While cesarean hysterectomy remains the most standard treatment for the management of PAS, expectant management is becoming increasingly prevalent to avoid serious maternal morbidity and maintain future fertility. Expectant management is defined as leaving the placenta either partially or fully in situ, and waiting for its spontaneous resorption or expulsion. The success rate of expectant management is high, but intraoperative uncontrolled hemorrhage results in hysterectomy. Moreover, some individuals fail expectant management and require delayed hysterectomy due to complications such as secondary postpartum hemorrhage, sepsis, uterine necrosis, and vesicouterine fistula. As a result of the very limited data currently available, there is no consensus on the optimal strategy for the expectant management of PAS. However, it is clear that a multidisciplinary team approach in tertiary centers is essential for women with PAS. In addition, meticulous preparation is the key to successful expectant management. Here, we describe a surgical strategy designed to reduce perioperative blood loss, which is a minimum requirement to ensure maternal safety. This article also addresses practical issues in expectant management of PAS, based on the published literature and our own experience. Thieme Medical Publishers, Inc. 2021-06-03 /pmc/articles/PMC8752198/ /pubmed/35036541 http://dx.doi.org/10.1055/s-0040-1722240 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Kondoh, Eiji
Expectant Management of Placenta Accreta Spectrum Disorders
title Expectant Management of Placenta Accreta Spectrum Disorders
title_full Expectant Management of Placenta Accreta Spectrum Disorders
title_fullStr Expectant Management of Placenta Accreta Spectrum Disorders
title_full_unstemmed Expectant Management of Placenta Accreta Spectrum Disorders
title_short Expectant Management of Placenta Accreta Spectrum Disorders
title_sort expectant management of placenta accreta spectrum disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752198/
https://www.ncbi.nlm.nih.gov/pubmed/35036541
http://dx.doi.org/10.1055/s-0040-1722240
work_keys_str_mv AT kondoheiji expectantmanagementofplacentaaccretaspectrumdisorders